SEC For 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing BPTH__20240913_8-K
Webcast link to the H.C. Wainwright 26th Annual Global Investment Conference – Monday, September 9, 2024 at 7:00 a.m. ET.
Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference BPTH_2024_HCW_Conference-Release
Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid Tumors BP1001-A_Solid_Tumor_Response_AML_Durability
Bio-Path Holdings Reports Second Quarter 2024 Financial Results BPTH_Second_Quarter_2024_Earnings_Release
Webcast link to Second Quarter 2024 Financial Results Conference Call – Thursday, August 15, 2024 at 8:30 a.m. ET
Bio-Path Holdings to Announce Second Quarter 2024 Financial Results on August 15, 2024 BPTH_Second_Quarter_2024_Earnings_Announcement
